Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutation

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 5, 1999, Pages 297-302

  Halbmayer, W M ^b   Kalhs, T ^c   Haushofer, A ^c   Breier, F ^a   Fischer, M ^c  

^a GENERAL HOSPITAL LINZ   (Austria)

^b Municipal Hospital Lainz   (Austria)

^c NONE

Author keywords

Coinheritance of thrombophilic mutations; Factor V Leiden mutation; Prothrombin gene mutation PT20210A; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN A;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; FAMILY STUDY; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MALE; ONSET AGE; PEDIGREE; PRIORITY JOURNAL; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0032777019     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199907000-00012     Document Type: Article

References (31)

1. 1. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
2. 2. Hillarp A, Zöller B, Svensson PJ, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78: 990-992.
3. 3. Cumming AM, Keenye S, Salden A, Bhavanani M, Shwe KH, Hay CRM. The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. Br J Haematol 1997; 98: 353-355.
4. 4. Arruda VR, Annichichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430-1433.
5. 5. Corral J, Gonzales-Conejero R, Lozano ML, Rivera J, Heras I, Vicente V. The venous thrombotic risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 1997; 99: 304-307.
6. 6. Gould J, Deam S, Dolan G. Prothrombin 20210A polymorphism and third generation contraceptives - a case report of coeliac axis thrombosis and splenic infarction. Thromb Haemost 1998; 79: 1214-1215.
7. 7. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90: 1747-1750.
8. 8. Doggen CJM, Manger Cats V, Bertina RM, Rosendaal FR. Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998; 67: 1037-1041.
9. 9. Martinelli I, Franchi F, Akwan S, Bettini P, Merati G, Mannucci PM. The transition G to A at position 20210 in the 3′-untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood 1997; 90: 3806.
10. 10. Halbmayer W-M, Haushofer A, Hermann K-M, Fischer M. The 20210A allele of the prothrombin gene: a risk factor for juvenile stroke? Result of a pilot study. Blood Coag Fibrinol 1998; 9: 209-210.
11. 11. De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998; 91: 3562-3565.
12. 12. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 1793-1797.
13. 13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
14. 14. Zivelin A, Griffin JH, Xiao Xu, Pabinger I, Samama M, Conard J, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997; 89: 397-402.
15. 15. Alhenc-Gelas M, Le Cam-Duchez V, Emmerich J, Frebourg T, Fiessinger JN, Borg JY, et al. The A20210 allele of the prothrombin gene is not frequently associated with the factor V arg 506 Gln mutation in thrombophilic patients. Blood 1997; 90: 1711.
16. 16. Zöller B, Svensson PJ, Dahlbäck B, Hillarp A. The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families. Blood 1998; 91: 2210-2211.
17. 17. Ehrenforth S, Ludwig S, Klinke S, Krause M, Scharrer I. The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia. Blood 1998; 91: 2209-2210.
18. 18. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, et al. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997; 78: 1426-1429.
19. 19. Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. Br J Haematol 1997; 98: 907-909.
20. 20. Scott CM, Hanley JP, Ludlam CA, Stirling D. Homozygosity for a factor II polymorphism associated with thrombosis during pregnancy [abstract]. Thromb Haemost 1997; 77 (suppl 1): 770.
21. 21. Howard TE, Marusa M, Channell C, Duncan A. A patient homozygous for a mutation in the prothrombin gene 3′-untranslated region associated with massive thrombosis. Blood Coag Fibrinol 1997; 8: 316-319.
22. 22. Weltermann A, Eichinger S, Stümpflen A, Hirschl M, Stain M, Mannhalter C, et al. Clinical and laboratory studies in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene [abstract]. Acta Med Austriaca 1998; 46 (suppl 1): 9.
23. 23. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78: 297-301.
24. 24. van Boven HA, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, et al. Factor V Leiden (FVR506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417-421.
25. 25. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-1035.
26. 26. Gandrille SG, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, et al. The French Network on behalf of INSERM. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 1995; 86: 219-224.
27. 27. Zöller B, He Xuhua, Dahlbäck B. Homozygous APC-resistance combined with inherited type 1 protein C deficiency in a young boy with severe thrombotic disease. Thromb Haemost 1995; 73: 743-745.
28. 28. Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 1995; 74: 580-583.
29. 29. Leroyer C, Mercier B, Oger E, Chenu E, Abgrall J-F, Ferec C, et al. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 1998; 80: 49-51.
30. 30. Veyradier A, Wolf M, Boyer-Neumann C, Parent F, Simonneau G, Meyer D. Recurrent thromboembolism in two unrelated patients with double heterozygosity for factor V R506Q and factor II 20210 G/A mutations. Thromb Haemost 1998; 80: 201-202.
31. 31. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia. Pathogenesis, clinical syndromes and management. Blood 1996; 87: 3531-3544.